Search

Both reports arose from the Danish project “NanoDEN”, commissioned by the Danish EPA.Environmental fate and behaviour of nanomaterials by Hartmann N, Skjolding L, Foss Hansen S, Gottschalk F, Baun A (2014)The report 1 provides an overview of the to date knowledge regarding processes relevant for environmental fate and behaviour of ENMs. Key environmental processes are identified, discussed and prioritized according to their relevance as inputs for fate modelling for ENMs. Furthermore, knowledge gaps are identified and prioritised with regard to

The production and use of nanoparticles leads to the emission of manufactured or engineered nanoparticles into the environment. Those particles undergo many possible reactions and interactions in the environment they are exposed to. These reactions and the resulting behavior and fate of nanoparticles in the environment have been studied for decades through naturally occurring nanoparticulate (1-100 nm) and colloidal (1-1000 nm) substances. The knowledge gained from these investigations is nowhere near sufficiently complete to create a detailed model of the

The present review covers developments in studies of nanomaterials (NMs) in the environment since our much cited review in 2008. We discuss novel insights into fate and behavior, metrology, transformations, bioavailability, toxicity mechanisms, and environmental impacts, with a focus on terrestrial and aquatic systems. Overall, the findings were that: 1) despite substantial developments, critical gaps remain, in large part due to the lack of analytical, modeling, and field capabilities, and also due to the breadth and complexity of the area

The German Environment Agency (UBA) webpage on advanced materials highlights UBA´s current preparatory research and thematic conferences on advanced materials. It reflects UBA´s opinion with regard to potential challenges and needs connected to advanced materials from the perspective of chemical safety, i.e. as summarized in a joint perspective paper on good governance developed by the higher federal authorities the German Federal Institute for Risk Assessment (BfR) and the Federal Institute for Occupational Safety and Health (BAuA) and UBA.

The German Environment Agency (UBA) webpage on nanotechnology indicates its activities and opinions as well as research efforts with regard to adequate regulation and safety assessment of manufactured nanomaterials and highlights relevant topics, actors, programs and networks including providing relevant links. Current research supervised by UBA is presented and finalized research is published as reports at this webpage.

The webpage presents OECD`s activities with regard to safety of manufactured nanomaterials starting back in 2006. By this, OECD intends to promote international co-operation in human health and environmental safety aspects of manufactured nanomaterials. The website provides publications developed within the OECD Working Party of Manufactured Nanomaterials, reports of previous workshops, projects and testing programs, the OECD council recommendation on safety testing and assessment of manufactured nanomaterials, but also videos of webinars on dedicated topics. Currently, one of the main

Scientific knowledge to assess the exposure to nanomaterials continues to improve. The OECD compiled an inventory of available models and tools for assessing occupational, consumer and environmental exposure to Nanomaterials. 54 tools and models were initially compiled and following in-depth analyses, 10 occupational, 7 consumer and 6 environmental tools/models were recommended or evaluated as suitable for assessing exposure to nanomaterials. The detailed information on the analyses and evaluations are provided in the reports accessible from the Series on Nanomaterials website

Pharmaceuticals in the environment are a global problem – more than 600 pharmaceuticals and their metabolites have been found in the environment worldwide.They enter the environment (through water, soil, sludge, and organisms) at all stages of their life cycle and can end up in drinking water, and accumulate in fish, vegetables, and livestock.This aim of the Safer Pharma campaign is to protect the environment from pharmaceutical pollution at all stage of their life cycle.The campaign is coordinated by Health Care

Лекарственные средства в окружающей среде являются глобальной проблемой - более 600 активных лекарственных веществ и их метаболитов обнаружены в окружающей среде во всем мире.Pharmaceuticals in the environment are a global problem – more than 600 pharmaceuticals and their metabolites have been found in the environment worldwide.They enter the environment (through water, soil, sludge, and organisms) at all stages of their life cycle and can end up in drinking water, and accumulate in fish, vegetables, and livestock.This aim of the Safer